AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,594,098 | -31.4% | 110,599 | -36.6% | 0.00% | 0.0% |
Q2 2023 | $8,149,739 | -59.0% | 174,550 | -66.4% | 0.00% | -63.6% |
Q1 2023 | $19,878,940 | -15.2% | 519,575 | +21.5% | 0.01% | -15.4% |
Q4 2022 | $23,437,028 | +5312.7% | 427,683 | +3260.7% | 0.01% | – |
Q3 2022 | $433,000 | +211.5% | 12,726 | -13.8% | 0.00% | – |
Q2 2022 | $139,000 | -40.6% | 14,763 | -10.7% | 0.00% | – |
Q1 2022 | $234,000 | -39.1% | 16,531 | -9.0% | 0.00% | – |
Q4 2021 | $384,000 | -53.5% | 18,171 | -50.8% | 0.00% | – |
Q3 2021 | $826,000 | -12.5% | 36,967 | -2.8% | 0.00% | – |
Q2 2021 | $944,000 | +8.0% | 38,045 | +26.3% | 0.00% | – |
Q1 2021 | $874,000 | -48.7% | 30,129 | -54.4% | 0.00% | -100.0% |
Q4 2020 | $1,704,000 | -53.9% | 66,055 | -45.0% | 0.00% | -66.7% |
Q3 2020 | $3,695,000 | +161.5% | 119,991 | +111.6% | 0.00% | +200.0% |
Q2 2020 | $1,413,000 | +2378.9% | 56,714 | +1996.6% | 0.00% | – |
Q1 2020 | $57,000 | +54.1% | 2,705 | +60.0% | 0.00% | – |
Q4 2019 | $37,000 | +27.6% | 1,691 | +28.4% | 0.00% | – |
Q3 2019 | $29,000 | – | 1,317 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |